...
首页> 外文期刊>The Biochemical Journal >The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins
【24h】

The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins

机译:H因子的C末端:单克隆抗体抑制肝素结合并鉴定H因子和H因子相关蛋白共有的表位

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We have generated monoclonal antibodies (mAbs) specific for the C-terminus of factor H that can be used as inhibitory antibodies for heparin binding and for the specific detection of factor H and factor H-related proteins (FHRs) in plasma and triacylglycerol-rich lipoproteins. Four distinct mAbs were established: IXF9 (IgG1), VD3 (IgG2a), VIG8 (IgG1) and IIC5 (IgG1). Each reacts specifically with FHR-1 and factor H (and also with FHR-2 in the case of VIG8), but none binds to the related FHR-3 and FHR-4 proteins nor to factor H-like protein 1. By the use of deletion mutants of factor H and by comparing the reactivity with FHR-1 and FHR-2, the binding epitopes of the mAbs were identified and localized to different short consensus repeats (SCRs): mAbs IXF9 and VD3 bind to related or even identical sites within SCR 18 (factor H) and SCR 3 (FHR-1) respectively. mAbs VIG8 and IIC5 bind to different epitopes located within SCRs 19 to 20 of factor H and SCRs 4 to 5 of FHR-1 respectively. Only mAb VIG8 reacts with the corresponding SCRs 3 to 4 of FHR-2. These antibodies are useful for the detection of the corresponding proteins in biological specimens such as fractions of lipoproteins. In addition, mAb VIG8 has the unique feature of inhibiting binding of factor H to heparin. Given the recent identification of a heparin- and a C3b-binding domain within the C-terminus of factor H, these mAbs should provide useful tools for functional analysis and for the precise localization of the domain(s) required for this interaction. [References: 37]
机译:我们已经生成了对因子H C端特异的单克隆抗体(mAb),可用作抑制肝素结合的抗体以及特异性检测富含血浆和三酰甘油的因子H和因子H相关蛋白(FHR)的抗体脂蛋白。建立了四个不同的mAb:IXF9(IgG1),VD3(IgG2a),VIG8(IgG1)和IIC5(IgG1)。它们各自与FHR-1和H因子发生特异性反应(在VIG8的情况下也与FHR-2发生反应),但均不与相关的FHR-3和FHR-4蛋白结合或与H样蛋白1结合。因子H缺失突变体的鉴定,并通过与FHR-1和FHR-2的反应性比较,鉴定了mAb的结合表位,并将其定位在不同的短共有重复序列(SCR)上:mAb IXF9和VD3结合到相关或什至相同的位点分别在SCR 18(因子H)和SCR 3(FHR-1)中。单克隆抗体VIG8和IIC5分别与位于因子H的SCR 19至20和FHR-1的SCR 4至5内的不同表位结合。只有mAb VIG8与FHR-2的相应SCR 3至4反应。这些抗体可用于检测生物样本中的相应蛋白质,例如脂蛋白级分。此外,mAb VIG8具有抑制H因子与肝素结合的独特功能。鉴于最近鉴定出了H因子C端内的肝素和C3b结合结构域,这些mAb应提供有用的工具用于功能分析和该相互作用所需结构域的精确定位。 [参考:37]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号